NCT04065399
Clinical Trial Detail
Contact
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04065399 |
| Title | A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation (AUGMENT-101) |
| Acronym | AUGMENT-101 |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | Yes |
| Sponsors | Syndax Pharmaceuticals |
| Indications | |
| Therapies | |
| Age Groups: | child | senior | adult |
| Covered Countries | USA | NLD | LTU | ITA | ISR | FRA | ESP | DEU | CAN | AUS |
CKB BOOST